News: Injectable contraceptives cause bone loss

Article

DMPA can cause bone loss in adolescent females.

After 2 years, adolescent girls using depot medroxyprogesterone acetate (DMPA) as their form of contraception had lower bone mineral density (BMD) determinations at the spine and femoral neck than girls using oral contraceptives (OCs) or neither forms of birth control, according to the results of an observational, prospective, cohort study.

Researchers included 433 postmenarcheal girls between the ages of 12 and 18 years. Over 2 years, mean percentage change in spine BMD for girls taking DMPA, OCs, or neither was –1.5%, +4.2%, and +6.3%, respectively. Mean percentage change in BMD at the femoral neck was –5.2%, +3.0%, and +3.8%, respectively.

Most of the decrease in BMD seen with DMPA occurred during the first year of use and then slowed during the second year. Decreases in BMD never approached a range consistent with osteopenia.

Recent Videos
Eran Bornstein, MD, highlights early signs of preeclampsia clinicians need to know | Image Credit: northwell.edu.
Eran Bornstein, MD explains the need for first trimester preeclampsia screening | Image Credit: northwell.edu.
Veerle Bergink, MD, PhD, highlights familial links of postpartum psychosis | Image Credit: profiles.mountsinai.org.
Ivie Odiase, MD
Susan Khalil, MD
Sharon Erdrich, PhD, discusses why oral health should be routine in health care | Image Credit: linkedIn.com.
Sharon Erdrich, PhD, highlights oral health's impact on chronic pain | Image Credit: linkedIn.com.
Fiona Gilbert, MA, MB, discusses breast cancer screening for dense breasts | Image Credit: newn.cam.ac.uk
Expert discussions from the 2025 ACOG meeting | Image Credit: © stevengaertner - © stevengaertner - stock.adobe.com.
Trina Mansour, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.